LUPIN Intraday Analysis...

LUPIN Share Price

Open 1055.00 Change Price %
High 1057.00 1 Day 2.00 0.19
Low 1046.30 1 Week -10.05 -0.95
Close 1051.20 1 Month 46.00 4.58
Volume 94104 1 Year -461.50 -30.51
52 Week High 1573.60
52 Week Low 917.55
LUPIN Important Levels
Resistance 2 1061.12
Resistance 1 1057.03
Pivot 1051.50
Support 1 1045.37
Support 2 1041.28
NSE INDIA Most Active Stocks
JPASSOCIAT 18.80 -0.53%
SUZLON 15.40 -0.96%
RCOM 16.40 -2.38%
SOUTHBANK 32.10 0.00%
IDEA 91.25 2.87%
JPPOWER 8.35 -1.18%
GVKPIL 13.40 4.69%
DCW 47.90 0.63%
HFCL 28.10 1.26%
SANWARIA 16.25 4.84%
More..
NSE INDIA Top Gainers Stocks
SOMICONVEY 61.20 20.00%
KARMAENG 51.20 19.21%
IFBAGRO 654.80 18.13%
PARABDRUGS 11.35 14.07%
LPDC 3.65 12.31%
PENPEBS 116.20 12.05%
SUJANAUNI 0.95 11.76%
SILINV 328.75 11.33%
SPYL 0.50 11.11%
GOKULAGRO 26.45 10.21%
More..
NSE INDIA Top Losers Stocks
SAMTEL 0.50 -9.09%
BILENERGY 0.60 -7.69%
MANAKINDST 38.50 -6.33%
EXCEL 87.40 -5.72%
NTL 3.50 -5.41%
NTL 3.50 -5.41%
SCAPDVR 4.75 -5.00%
TVVISION 58.75 -4.94%
XLENERGY 2.90 -4.92%
CALSOFT 31.00 -4.91%
More..

Lupin Limited (NSE: LUPIN)

LUPIN Technical Analysis 2
As on 19th Oct 2017 LUPIN Share Price closed @ 1051.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1271.10 & Strong Buy for SHORT-TERM with Stoploss of 999.79 we also expect STOCK to react on Following IMPORTANT LEVELS.
LUPIN Target for October
1st Target up-side 1060.05
2nd Target up-side 1092.33
3rd Target up-side 1124.61
1st Target down-side 967.95
2nd Target down-side 935.67
3rd Target down-side 903.39
LUPIN Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
LUPIN Other Details
Segment EQ
Market Capital 167129956352.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.lupinworld.com
LUPIN Address
LUPIN
Laxmi Towers, B Wing
Bandra Kurla Complex
Mumbai, 400051
India
Phone: 91 22 6640 2222
Fax: 91 22 6640 2130
LUPIN Latest News
Interactive Technical Analysis Chart Lupin Limited ( LUPIN NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lupin Limited
LUPIN Business Profile
Lupin is in the Pharmaceuticals sector.Lupin was founded in 1968. Lupin Limited is a transnational pharmaceutical company based in Mumbai. It is the 2nd largest Indian pharma company by market capitalization; the 14th largest generic pharmaceutical company globally and; the 5th largest generic pharmaceutical company in the US by prescription-led market share.It has the distinction of being the fastest growing generic pharmaceutical player in the two largest pharmaceutical markets of the world – the US and Japan;and is the 5th largest and the fastest growing generic pharmaceutical player in South Africa. The current market capitalisation stands at Rs 38,843.21 crore.The company has reported a consolidated sales of Rs 2667.87 crore and a Net Profit of Rs 417.28 crore for the quarter ended Sep 2013. The company management includes Desh Bandhu Gupta - Chairman, Kamal K Sharma - Managing Director, M D Gupta - Executive Director, Nilesh Gupta - Executive Director, Vinita Gupta - Director, Vijay Kelkar - Director, Richard Zahn - Director, R A Shah - Director, K U Mada - Director, Dileep C Choksi - Additional Director. It is listed on the BSE with a BSE Code of 500257 and the NSE with an NSE Code of LUPIN.